News

The U.S. Food and Drug Administration has approved the ketamine product, KETARx, for use in surgical pain management.
After a more than decadelong process to bring the experimental drug elamipretide to market, the treatment’s approval has ...
CNBC's Angelica Peebles joins 'Squawk on the Street' to discuss the latest news on Novo Nordisk, what new FDA approval on its ...
Novo Nordisk shares climbed after the U.S. Food and Drug Administration approved a new indication for the Danish drugmaker’s ...
A series of panels convened by the Food and Drug Administration is raising concerns that the agency is skirting federal rules ...
The FDA’s recent issue of five warning letters to brands illegally marketing whipped, mousse and foam sunscreen products ...
Robert F. Kennedy Jr. has said the CDC's vaccine advisory board was rife with conflicts of interest. A new analysis shows ...
With a new endorsement from the FDA, Novo Nordisk’s Wegovy has picked up its third indication and become the second drug ...
The biotech, which cut jobs following the rejection in May of its Barth syndrome therapy, claimed it has addressed the agency ...
Sublingual cyclobenzaprine (Tonmya), a nonopioid treatment for adults with fibromyalgia, targets nonrestorative sleep, a root ...
Federal health officials are warning sunscreen companies for violating drug regulations by selling products in unapproved ...
A new study shows access to birth control has increased following the FDA's approval of an over-the-counter birth control pill. In the two years since the pill went on the market, there's a 31.8% ...